Abstract
A standardized protocol is demonstrated for bioluminescent strains Saccharomyces cerevisiae BLYES, BLYAS and BLYR as high-throughput screening tools to monitor the estrogenic, androgenic and toxic potencies in wastewater. The sensitivity and reproducibility of the assay in wastewater monitoring was evaluated for 7 day semi-continuous batch reactor using activated sludge with hormones spiked raw sewage. Yeast bioluminescent assay successfully captured the rapid removal of estrogenic and androgenic activities in the bioreactors, and demonstrated rapid response (≤4 h) with good reproducibility. This standardized protocol was then applied in a 12 months monitoring of the effluent of a WWTP located at Powell, TN, USA featuring parallel-operated full-scale membrane bioreactor (MBR) and traditional activated sludge (TAS) treatment. Monitoring results showed that estrogenic activity was persistent in all TAS and most MBR effluent samples, while residual androgenic activity was non-detectable throughout the monitored period. The estrogenic equivalents (EEQ) in TAS effluent ranged from 21.61 ng/L to 0.04 pg/L and averaged 3.25 ng/L. The EEQ in MBR effluent ranged from 2.88 ng/L to 0.0134 pg/L and averaged ~10 fold less (0.32 ng/L) than TAS. Despite the large temporal variation, MBR effluent EEQ was consistently lower than TAS on any given sampling date. Most MBR effluent samples also exhibited less cytotoxicity than TAS. Further analysis did not demonstrate significant correlation between effluent EEQ level and WWTP operational parameters including MLSS, SRT, HRT and BOD.
Similar content being viewed by others
References
Chang H-S, Choo K-H, Lee B, Choi S-J (2009) The methods of identification, analysis, and removal of endocrine disrupting compounds (EDCs) in water. J Hazard Mater 172:1–12
Clara M, Kreuzinger N, Strenn B, Gans O, Kroiss H (2005a) The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39:97–106. doi:10.1016/j.watres.2004.08.036
Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H (2005b) Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39:4797–4807
Di Dea Bergamasco AM et al (2011) Bioluminescent yeast estrogen assay (BLYES) as a sensitive tool to monitor surface and drinking water for estrogenicity. J Environ Monit 13:3288–3293. doi:10.1039/C1EM10464K
Drewes JE, Hemming J, Schauer JJ, Sonzogni W (2006) Removal of endocrine disrupting compounds in water reclamation processes. Water Environment Research Foundation: Wastewater Treatment and Reuse, Final Report
Eldridge ML, Sanseverino J, Layton AC, Easter JP, Schultz TW, Sayler GS (2007) Saccharomyces cerevisiae BLYAS, a new bioluminescent bioreporter for detection of androgenic compounds. Appl Environ Microbiol 73:6012–6018
Frye C et al (2012) Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J Neuroendocrinol 24:144–159. doi:10.1111/j.1365-2826.2011.02229.x
Gaulke LS, Strand SE, Kalhorn TF, Stensel HD (2009) Estrogen biodegradation kinetics and estrogenic activity reduction for two biological wastewater treatment methods. Environ Sci Technol 43:7111–7116
Hashimoto T, Murakami T (2009) Removal and degradation characteristics of natural and synthetic estrogens by activated sludge in batch experiments. Water Res 43:573–582. doi:10.1016/j.watres.2008.10.051
Holbrook RD, Novak JT, Grizzard TJ, Love NG (2002) Estrogen receptor agonist fate during wastewater and biosolids treatment processes: a mass balance analysis. Environ Sci Technol 36:4533–4539
Hu J, Chen X, Tao G, Kekred K (2007) Fate of endocrine disrupting compounds in membrane bioreactor systems. Environ Sci Technol 41:4097–4102
Judd S (2008) The status of membrane bioreactor technology. Trends Biotechnol 26:109–116
Kabir ER, Rahman MS, Rahman I (2015) A review on endocrine disruptors and their possible impacts on human health. Environ Toxicol Pharmacol 40:241–258. doi:10.1016/j.etap.2015.06.009
Kim SD, Cho J, Kim IS, Vanderford BJ, Snyder SA (2007) Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 41:1013–1021
Kimura K, Hara H, Watanabe Y (2007) Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 41:3708–3714. doi:10.1021/es061684z
Kirk LA, Tyler CR, Lye CM, Sumpter JP (2002) Changes in estrogenic and androgenic activities at different stages of treatment in wastewater treatment works. Environ Toxicol Chem 21:972–979
Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211
Krifaton C et al (2013) Application of a yeast estrogen reporter system for screening zearalenone degrading microbes. J Hazard Mater 244:429–435
Lee DG, Zhao F, Rezenom YH, Russell DH, Chu K-H (2012) Biodegradation of triclosan by a wastewater microorganism. Water Res 46:4226–4234
Liu Z-h, Kanjo Y, Mizutani S (2009) Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment—physical means, biodegradation, and chemical advanced oxidation: a review. Sci Total Environ 407:731–748. doi:10.1016/j.scitotenv.2008.08.039
Luo Y et al (2014) A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci Total Environ 473:619–641
Martin OV, Lai KM, Scrimshaw MD, Lester JN (2005) Receiver operating characteristic analysis for environmental diagnosis. A potential application to endocrine disruptor screening: in vitro estrogenicity bioassays. Environ Sci Technol 39:5349–5355. doi:10.1021/es048598o
Murk AJ et al (2002) Detection of estrogenic potency in wastewater and surface water with three in vitro bioassays. Environ Toxicol Chem 21:16–23
Osimitz TG et al (2012) Lack of androgenicity and estrogenicity of the three monomers used in Eastman’s Tritan™ copolyesters. Food Chem Toxicol 50:2196–2205
Purvis IJ, Chotai D, Dykes CW, Lubahn DB, French FS, Wilson EM, Hobden AN (1991) An androgen-inducible expression system for Saccharomyces cerevisiae. Gene 106:35–42
Radjenović J, Petrović M, Barceló D (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43:831–841
Routledge EJ, Sumpter JP (1996) Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15:241–248
Ruan T, Liang D, Song S, Song M, Wang H, Jiang G (2015) Evaluation of the in vitro estrogenicity of emerging bisphenol analogs and their respective estrogenic contributions in municipal sewage sludge in China. Chemosphere 124:150–155
Sanseverino J et al (2005) Use of Saccharomyces cerevisiae BLYES expressing bacterial bioluminescence for rapid, sensitive detection of estrogenic compounds. Appl Environ Microbiol 71:4455–4460
Sanseverino J, Eldridge ML, Layton AC, Easter JP, Yarbrough J, Schultz TW, Sayler GS (2009) Screening of potentially hormonally active chemicals using bioluminescent yeast bioreporters. Toxicol Sci 107:122–134. doi:10.1093/toxsci/kfn229
Servos M et al (2005) Distribution of estrogens, 17β-estradiol and estrone, in Canadian municipal wastewater treatment plants. Sci Total Environ 336:155–170
Suzuki Y, Maruyama T (2006) Fate of natural estrogens in batch mixing experiments using municipal sewage and activated sludge. Water Res 40:1061–1069
Svenson A, Allard A-S, Ek M (2003) Removal of estrogenicity in Swedish municipal sewage treatment plants. Water Res 37:4433–4443
Tanaka H, Yakou Y, Takahashi A, Higashitani T, Komori K (2001) Comparison between estrogenicities estimated from DNA recombinant yeast assay and from chemical analyses of endocrine disruptors during sewage treatment. Water Sci Technol 43:125–132
Vega-Morales T, Sosa-Ferrera Z, Santana-Rodríguez J (2013) Evaluation of the presence of endocrine-disrupting compounds in dissolved and solid wastewater treatment plant samples of Gran Canaria Island (Spain). Biomed Res Int. doi:10.1155/2013/790570
Vethaak AD et al (2005) An integrated assessment of estrogenic contamination and biological effects in the aquatic environment of The Netherlands. Chemosphere 59:511–524
Acknowledgments
This work was supported by University of Tennessee, Center for Environmental Biotechnology and Tennessee Department of Environment and Conservation. The authors thank Hallsdale-Powell Utility District (Powell, TN) for kindly assisting and providing the wastewater samples and WWTP operational parameters.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no specific conflict of interest. But GSS has general commercial interest in bioluminescent reporters through 490 Biotech.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, J., Eldridge, M., Menn, Fm. et al. Standardized application of yeast bioluminescent reporters as endocrine disruptor screen for comparative analysis of wastewater effluents from membrane bioreactor and traditional activated sludge. Ecotoxicology 24, 2088–2099 (2015). https://doi.org/10.1007/s10646-015-1556-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10646-015-1556-z